Literature DB >> 8490989

Epidemiology of epilepsy in developing countries.

N Senanayake1, G C Román.   

Abstract

Epilepsy is an important health problem in developing countries, where its prevalence can be up to 57 per 1000 population. This article reviews the epidemiology of epilepsy in developing countries in terms of its incidence, prevalence, seizure type, mortality data, and etiological factors. The prevalence of epilepsy is particularly high in Latin America and in several African countries, notably Liberia, Nigeria, and the United Republic of Tanzania. Parasitic infections, particularly neurocysticercosis, are important etiological factors for epilepsy in many of these countries. Other reasons for the high prevalence include intracranial infections of bacterial or viral origin, perinatal brain damage, head injuries, toxic agents, and hereditary factors. Many of these factors are, however, preventable or modifiable, and the introduction of appropriate measures to achieve this could lead to a substantial decrease in the incidence of epilepsy in developing countries.

Entities:  

Mesh:

Year:  1993        PMID: 8490989      PMCID: PMC2393447     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  55 in total

1.  Pilot survey of the prevalence of neurologic disorders in the Parsi community of Bombay.

Authors:  N E Bharucha; E P Bharucha; H D Dastur; B S Schoenberg
Journal:  Am J Prev Med       Date:  1987 Sep-Oct       Impact factor: 5.043

2.  Japanese encephalitis--a plague of the Orient.

Authors:  T P Monath
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

3.  Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 patients and review of the literature.

Authors:  R Teoh; M J Humphries; G O'Mahony
Journal:  Q J Med       Date:  1987-05

4.  [Prevalence of neurologic diseases in Belisario Porras municipality, District of San Miguelito, Panama, 1986].

Authors:  F J Gracia; V Bayard; E Triana; L C Castillo; A Benzadón; M Larreátegui; R Cerrud; S Politis
Journal:  Rev Med Panama       Date:  1988-01

5.  Focal epilepsy in India with special reference to lesions showing ring or disc-like enhancement on contrast computed tomography.

Authors:  R S Wadia; C N Makhale; A V Kelkar; K B Grant
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

6.  The risk of unprovoked seizures after encephalitis and meningitis.

Authors:  J F Annegers; W A Hauser; E Beghi; A Nicolosi; L T Kurland
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

7.  Prevalence of the epilepsies in Nigerian Africans: a community-based study.

Authors:  B O Osuntokun; A O Adeuja; V A Nottidge; O Bademosi; A Olumide; O Ige; F Yaria; C L Bolis; B S Schoenberg
Journal:  Epilepsia       Date:  1987 May-Jun       Impact factor: 5.864

8.  Prevalence and pattern of epilepsy (Lath/Mirgi/Laran) in rural Kashmir, India.

Authors:  R Koul; S Razdan; A Motta
Journal:  Epilepsia       Date:  1988 Mar-Apr       Impact factor: 5.864

9.  Prevalence of epilepsy in the Parsi community of Bombay.

Authors:  N E Bharucha; E P Bharucha; A E Bharucha; A V Bhise; B S Schoenberg
Journal:  Epilepsia       Date:  1988 Mar-Apr       Impact factor: 5.864

10.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more
  45 in total

1.  The natural history of epilepsy: spontaneous remission and mortality.

Authors:  Dale C Hesdorffer
Journal:  Epilepsy Curr       Date:  2010-05       Impact factor: 7.500

2.  Prevalence case-control study of epilepsy in three Burkina Faso villages.

Authors:  P Nitiéma; H Carabin; S Hounton; N Praet; L D Cowan; R Ganaba; C Kompaoré; Z Tarnagda; P Dorny; A Millogo
Journal:  Acta Neurol Scand       Date:  2012-01-31       Impact factor: 3.209

3.  Attitudes towards African traditional medicine and Christian spiritual healing regarding treatment of epilepsy in a rural community of northern Tanzania.

Authors:  Andrea Sylvia Winkler; Michael Mayer; Michael Ombay; Bartholomayo Mathias; Erich Schmutzhard; Louise Jilek-Aall
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-12-30

Review 4.  Neurocysticercosis and epilepsy in developing countries.

Authors:  D K Pal; A Carpio; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

5.  NEUROLOGICAL INFECTIONS IN THE RETURNING INTERNATIONAL TRAVELER.

Authors:  May H Han; Melanie Walker; Joseph R Zunt
Journal:  Continuum (Minneap Minn)       Date:  2006-04

6.  Why should modified Atkins diet be encouraged for treating epilepsy in emerging countries?

Authors:  Amal Satte; Eric Heath Kossoff; Mohamed Belghiti; Abderrahim Zerhouni; Hamid Ouhabi; Hassania Guerinech; Jamal Mounach
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

Review 7.  A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy.

Authors:  Patrick C Ndimubanzi; Hélène Carabin; Christine M Budke; Hai Nguyen; Ying-Jun Qian; Elizabeth Rainwater; Mary Dickey; Stephanie Reynolds; Julie A Stoner
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

8.  The prevalence of epilepsy follows the distribution of onchocerciasis in a west Ugandan focus.

Authors:  C Kaiser; W Kipp; G Asaba; C Mugisa; G Kabagambe; D Rating; M Leichsenring
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

Review 9.  WHO's work on the epidemiology of mental disorders.

Authors:  N Sartorius
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-08       Impact factor: 4.328

10.  MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: an observational study.

Authors:  A S Winkler; K Friedrich; S Velicheti; J Dharsee; R König; A Nassri; M Meindl; A Kidunda; T H Müller; L Jilek-Aall; W Matuja; T Gotwald; E Schmutzhard
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.